Silvia Pesce

2.6k total citations
46 papers, 2.0k citations indexed

About

Silvia Pesce is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Silvia Pesce has authored 46 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Immunology, 19 papers in Oncology and 7 papers in Hematology. Recurrent topics in Silvia Pesce's work include Immune Cell Function and Interaction (38 papers), T-cell and B-cell Immunology (22 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Silvia Pesce is often cited by papers focused on Immune Cell Function and Interaction (38 papers), T-cell and B-cell Immunology (22 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Silvia Pesce collaborates with scholars based in Italy, Sweden and France. Silvia Pesce's co-authors include Emanuela Marcenaro, Lorenzo Moretta, Alessandro Moretta, Simona Sivori, Marco Greppi, Simona Carlomagno, Silvia Parolini, Giovanna Tabellini, Fabio Rampinelli and Alessandro Moretta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Silvia Pesce

45 papers receiving 2.0k citations

Peers

Silvia Pesce
Victor H. Salinas United States
Haoyu Sun China
William D. Hastings United States
Mie Nieda Japan
Jason Foley United States
Silvia Pesce
Citations per year, relative to Silvia Pesce Silvia Pesce (= 1×) peers Genny Del Zotto

Countries citing papers authored by Silvia Pesce

Since Specialization
Citations

This map shows the geographic impact of Silvia Pesce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Pesce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Pesce more than expected).

Fields of papers citing papers by Silvia Pesce

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Pesce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Pesce. The network helps show where Silvia Pesce may publish in the future.

Co-authorship network of co-authors of Silvia Pesce

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Pesce. A scholar is included among the top collaborators of Silvia Pesce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Pesce. Silvia Pesce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greppi, Marco, Valentina Obino, Davide Frumento, et al.. (2024). NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances. Immunology Letters. 270. 106932–106932. 12 indexed citations
3.
Obino, Valentina, Daniela Fenoglio, Camilla Jandus, et al.. (2024). The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer. Cancer Treatment Reviews. 130. 102831–102831. 8 indexed citations
4.
Moghaddam, Farnaz Dabbagh, Silvia Pesce, Chiara Cencioni, et al.. (2024). Crosstalk and communication of cancer-associated fibroblasts with natural killer and dendritic cells: New frontiers and unveiled opportunities for cancer immunotherapy. Cancer Treatment Reviews. 131. 102843–102843. 17 indexed citations
5.
Minetto, Paola, Marco Greppi, Silvia Pesce, et al.. (2023). Harnessing Immune Response in Acute Myeloid Leukemia. Journal of Clinical Medicine. 12(18). 5824–5824. 8 indexed citations
6.
Greppi, Marco, Valentina Obino, Simona Carlomagno, et al.. (2023). Identification of a novel cord blood NK cell subpopulation expressing functional programmed death receptor-1. Frontiers in Immunology. 14. 1183215–1183215. 4 indexed citations
7.
Paudice, Michele, Marco Greppi, Serafina Mammoliti, et al.. (2023). The fading guardian: clinical relevance of TP53 null mutation in high-grade serous ovarian cancers. Frontiers in Immunology. 14. 1221605–1221605. 6 indexed citations
8.
Pesce, Silvia, et al.. (2023). NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells. Journal for ImmunoTherapy of Cancer. 11(8). e007202–e007202. 9 indexed citations
9.
Rosa, Alfredo De, Marco Greppi, Roberto Pistilli, et al.. (2023). A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans. Frontiers in Immunology. 14. 1216107–1216107. 10 indexed citations
10.
Rutigliani, Mariangela, Andrea Barberis, Marco Greppi, et al.. (2022). Case Report: A Peculiar Case of Inflammatory Colitis After SARS-CoV-2 Infection. Frontiers in Immunology. 13. 849140–849140. 8 indexed citations
11.
Provinciali, Nicoletta, Marco Greppi, Silvia Pesce, et al.. (2022). Case report: Variable response to immunotherapy in ovarian cancer: Our experience within the current state of the art. Frontiers in Immunology. 13. 1094017–1094017. 1 indexed citations
12.
Pesce, Silvia, Marco Greppi, Elisa Ferretti, et al.. (2020). miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy. Frontiers in Cell and Developmental Biology. 8. 119–119. 33 indexed citations
13.
Christenson, Karin, et al.. (2019). Downregulation of HLA Class I Renders Inflammatory Neutrophils More Susceptible to NK Cell-Induced Apoptosis. Frontiers in Immunology. 10. 2444–2444. 11 indexed citations
14.
Vito, Clara Di, Joanna Mikulak, Elisa Zaghi, et al.. (2019). NK cells to cure cancer. Seminars in Immunology. 41. 101272–101272. 73 indexed citations
15.
Pesce, Silvia, Margherita Squillario, Marco Greppi, et al.. (2018). New miRNA Signature Heralds Human NK Cell Subsets at Different Maturation Steps: Involvement of miR-146a-5p in the Regulation of KIR Expression. Frontiers in Immunology. 9. 2360–2360. 42 indexed citations
16.
Pesce, Silvia, Fredrik B. Thorén, Claudia Cantoni, et al.. (2017). The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands. Frontiers in Immunology. 8. 510–510. 28 indexed citations
17.
Pesce, Silvia, Marco Greppi, Giovanna Tabellini, et al.. (2016). Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization. Journal of Allergy and Clinical Immunology. 139(1). 335–346.e3. 369 indexed citations
18.
Chiesa, Mariella Della, Silvia Pesce, Letizia Muccio, et al.. (2016). Features of Memory-Like and PD-1+ Human NK Cell Subsets. Frontiers in Immunology. 7. 351–351. 94 indexed citations
19.
Sivori, Simona, Simona Carlomagno, Silvia Pesce, et al.. (2014). TLR/NCR/KIR: Which One to Use and When?. Frontiers in Immunology. 5. 105–105. 63 indexed citations
20.
Marcenaro, Emanuela, Simona Carlomagno, Silvia Pesce, Alessandro Moretta, & Simona Sivori. (2011). NK/DC Crosstalk in Anti-viral Response. Advances in experimental medicine and biology. 946. 295–308. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026